Security National (SNFCA) director adds stock units and exercises 616 shares
Rhea-AI Filing Summary
SECURITY NATIONAL FINANCIAL CORP director Moody H. Craig reported equity compensation activity rather than open-market trading. On July 1, 2026, he exercised 616 shares of Class A Common Stock at $8.53 per share and held 50,093 shares directly afterward.
He also has restricted stock unit awards, including grants for 1,846 and 616 units at $8.53 per share that vest quarterly and are scheduled to be fully vested by December 31, 2026 under the 2022 Equity Incentive Plan. Earlier director stock options from 2017–2023 remain reflected at adjusted share amounts and exercise prices due to anti-dilution adjustments for multiple stock dividends.
Positive
- None.
Negative
- None.
Insights
Routine director equity grants and one small option exercise, no selling.
The filing shows Moody H. Craig, a director of SECURITY NATIONAL FINANCIAL CORP, engaging solely in equity compensation-related activity. The only common stock movement is exercising 616 shares at $8.53, bringing direct holdings to 50,093 shares, with no sales reported.
The derivative entries are grants of restricted stock units and director stock options awarded over several years, all coded as acquisitions. Footnotes describe anti-dilution adjustments for repeated stock dividends and RSUs vesting quarterly through December 31, 2026. With no dispositions or open-market trades, this looks like standard board compensation reporting, so the impact on an investment thesis is neutral.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 616 | $8.53 | $5K |
| Exercise | Class A Common Stock | 616 | $8.53 | $5K |
| Grant/Award | Restricted Stock Unit | 1,846 | $8.53 | $16K |
| Grant/Award | Director Stock Option (right to buy) | 8,820 | $7.21 | $64K |
| Grant/Award | Director Stock Option (right to buy) | 8,104 | $5.56 | $45K |
| Grant/Award | Director Stock Option (right to buy) | 7,293 | $7.02 | $51K |
| Grant/Award | Director Stock Option (right to buy) | 7,850 | $2.84 | $22K |
| Grant/Award | Director Stock Option (right to buy) | 8,242 | $3.91 | $32K |
| Grant/Award | Director Stock Option (right to buy) | 8,657 | $3.76 | $33K |
| Grant/Award | Director Stock Option (right to buy) | 1,514 | $3.27 | $5K |
Footnotes (1)
- This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025. This option was granted on November 30, 2018 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025. This option was granted on December 6, 2019 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.46 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025. This option was granted on March 27, 2020 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $3.76 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 7, 2020, a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025. This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025. This option was granted on December 2, 2022 as an option for 7,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $6.48, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 14, 2023, July 12, 2024 and July 18, 2025. This option was granted on December 1, 2023 as an option for 8,000 shares of Class A Common Stock under the 2022 Equity Incentive Plan at an exercise price of $7.99 per share, but adjusted pursuant to the 2022 Equity Incentive Plan to reflect a 5% stock dividend paid on July 12, 2024 and July 18, 2025. These restricted stock units were granted on December 5, 2025 for 2,461 shares of Class A Common Stock under the 2022 Equity Incentive Plan at a price of $8.53 per share. The units granted vest quarterly, and will be fully vested on December 31, 2026.